Characterization of RFB4-Pseudomonas exotoxin A immunotoxins targeted to CD22 on B-cell malignancies

Bioconjugate Chemistry

Volumn 7, Issue 5, 1996, Pages 557-563

  Mansfield, Elizabeth ^a   Pastan, Ira ^a   FitzGerald, David J ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL CULTURE; CELL MEMBRANES; COVALENT BONDS; CYTOTOXICITY; ENDOTHELIAL CELLS; ENZYME ACTIVITY; SULFUR COMPOUNDS;

ADP-RIBOSYLATION; B CELLS; BINDING SEQUENCE; CELL LINES; DISULPHIDE BONDS; IMMUNOTOXINS; PROTEOLYTIC CLEAVAGE; PSEUDOMONAS EXOTOXIN A; RECEPTOR BINDING; THIOETHER BONDS;

BACTERIA;

ANIMALIA; BACTERIA (MICROORGANISMS); MUS MUSCULUS; PSEUDOMONAS; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS EXOTOXIN;

EID: 0030250422     PISSN: 10431802     EISSN: None     Source Type: Journal    
DOI: 10.1021/bc960043y     Document Type: Article

References (30)

1. Uckun, F. M., Manivel, C., Arthur, D., Chelstrom, L. M., Finnegan, D., Tuel-Ahlgren, L., Irvin, J. D., Myers, D. E., and Gunther, R. (1992) In vivo efficacy of B43 (anti-CD19)-pokeweed antiviral protein immunotoxin against human pre-B cell acute lymphoblastic leukemia in mice with severe combined immunodeficiency. Blood 79, 2201-2214.
2. Ghetie, M.-A., Richardson, J., Tucker, T., Jones, D., Uhr, J. W., and Vitetta, E. S. (1991) Antitumor activity of Fab′ and IgG-anti-CD22 immunotoxins in disseminated human B lymphoma grown in mice with severe combined immunodeficiency disease: Effect on tumor cells in extranodal sites. Cancer Res. 51, 5876-5880.
3. Francisco, J. A., Gilliland, L. K., Stebbins, M. R., Norris, N. A., Ledbetter, J. A., and Siegall, C. B. (1995) Activity of a single-chain immunotoxin that selectively kills lymphoma and other B-lineage cells expressing the CD40 antigen. Cancer Res. 55, 3099-3104.
4. Ghetie, M.-A., May, R. D., Till, M., Uhr, J. W., Ghetie, V., Knowles, P. P., Relf, M., Brown, A., Wallace, P. M., Janossy, G., Amlot, P., Vitetta, E. S., and Thorpe, P. E. (1988) Evaluation of ricin A chain-containing immunotoxins directed against CD19 and CD22 antigens on normal and malignant human B-cells as potential reagents for in vivo therapy. Cancer Res. 48, 2610-2617.
5. Bonardi, M. A., French, R. R., Amlot, P., Gromo, G., Modena, D., and Glennie, M. J. (1993) Delivery of saporin to human B-cell lymphoma using bispecific antibody: Targeting via CD22 but not CD19, CD37, or immunoglobulin results in efficient killing. Cancer Res. 53, 3015-3021.
6. French, R. R., Penney, C. A., Browning, A. C., Stirpe, F., George, A. J. T., and Glennie, M. J. (1995) Delivery of the ribosome-inactivating protein, gelonin, to lymphoma cells via CD22 and CD38 using bispecific antibodies. Br. J. Cancer 71, 986-994.
7. Uckun, F. M., Ramakrishnan, S., and Houston, L. L. (1985) Immunotoxin-mediated elimination of clonogenic tumor cells in the presence of human bone marrow. J. Immunol. 134, 2010-2016.
8. Kreitman, R. J., Hansen, H. J., Jones, A. L., FitzGerald, D. J. P., Goldenberg, D. M., and Pastan, I. (1993) Pseudomonas exotoxin-based immunotoxins containing the antibody LL2 or LL2-Fab′ induce regression of subcutaneous human B-cell lymphoma in mice. Cancer Res. 53, 819-825.
9. 280 generates the enzymatically active fragment which translocates to the cytosol. J. Biol. Chem. 267, 25396-25401.
10. Theuer, C. P., Kreitman, R. J., FitzGerald, D. J., and Pastan, I. (1993) Immunotoxins made with a recombinant form of Pseudomonas exotoxin A that do not require proteolysis for activity. Cancer Res. 53, 340-347.
11. Kreitman, R. J., Chaudhary, V. K., Kozak, R. W., FitzGerald, D. J. P., Waldmann, T. A., and Pastan, I. (1992) Recombinant toxins containing the variable domains of the anti-Tac monoclonal antibody to the interleukin-2 receptor kill malignant cells from patients with chronic lymphocytic leukemia. Blood 80, 2344-2352.
12. Campana, D., Janossy, G., Bofill, M., Trejdosiewicz, L. K., Ma, D., Hoffbrand, V., Mason, D. Y., Lebacq, A.-M., and Forster, H. K. (1985) Human B cell development. I. Phenotypic differences of B lymphocytes in the bone marrow and peripheral lymphoid tissue. J. Immunol. 134, 1524-1530.
13. Li, J.-L., Shen, G.-L., Ghetie, M.-A., May, R. D., Till, M., Ghetie, V., Uhr, J. W., Janossy, G., Thorpe, P. E., Amlot, P., and Vitetta, E. S. (1989) The epitope specificity and tissue reactivity of four murine monoclonal anti-CD22 antibodies. Cell. Immunol. 118, 85-99.
14. Vitetta, E. S., Stone, M., Amlot, P., Fay, J., May, R., Till, M., Newman, J., Clark, P., Collins, R., Cunningham, D., Ghetie, V., Uhr, J. W., and Thorpe, P. E. (1991) Phase I immunotoxin trial in patients with B cell lymphoma. Cancer Res. 51, 4052-4058.
15. Amlot, P., Stone, M. J., Cunningham, D., Fay, J., Newman, J., Collins, R., May, R., McCarthy, M., Richardson, J., Ghetie, V., Ramilo, O., Thorpe, P. E., Uhr, J. W., and Vitetta, E. S. (1993) A phase I study of anti-CD22 deglycosylated ricin A chain immunotoxin in the treatment of B cell lymphomas resistant to conventional therapy. Blood 82, 2624.
16. Sausville, E. A., Headlee, D., Stetler-Stevenson, M., Jaffe, E. S., Solomon, D., Figg, W. D., Herdt, J., Kopp, W. C., Rager, H., Steinberg, S. M., Ghetie, V., Schindler, J., Uhr, J., Wittes, R. E., and Vitetta, E. S. (1995) Continuous infusion of the anti-CD22 immunotoxin IgG-RFB4-SMPT-dgA in patients with B-cell lymphoma: A phase I study. Blood 85, 3457-3465.
17. Ghetie, V., Thorpe, P., Ghetie, M. A., Knowles, P., Uhr, J. W., and Vitetta, E. S. (1991) The GLP large scale preparation of immunotoxins containing deglycosylated ricin A chain and a hindered disulfide bond. J. Immunol. Methods 142, 223-230.
18. FitzGerald, D. J. P. (1987) Construction of immunotoxins using Pseudomonas exotoxin A. Methods Enzymol. 151, 139-145.
19. Soler-Rodriguez, A.-M., Ghetie, M.-A., Oppenheimer-Marks, N., Uhr, J. W., and Vitetta, E. S. (1993) Ricin A-chain and ricin A-chain immunotoxins rapidly damage human endothelial cells: Implications for vascular leak syndrome. Exp. Cell. Res. 206, 227-234.
20. Anderson, K. C., Bates, M. P., Slaughenhoupt, B. L., Pinkus, G. S., Schlossman, S. F., and Nadler, L. M. (1984) Expression of human B cell-associated antigens on leukemias and lymphomas: A model of human B cell differentiation. Blood 63, 1424-1433.
21. Ghetie, M.-A., Richardson, J., Tucker, T., Jones, D., Uhr, J. W., and Vitetta, E. S. (1990) Disseminated or localized growth of a human B-cell tumor (Daudi) in SCID mice. Int. J. Cancer 45, 481-485.
22. Pai, L. H., Wittes, R. E., Setser, A., Goldspiel, B., FitzGerald, D., Willingham, M. C., and Pastan, I. (1994) Phase I study of the immunotoxin LMB-1, an anti-cancer murine MAb B3, coupled to a recombinant form of Pseudomonas exotoxin. Proc. Am. Assoc. Cancer Res. 35, 507.
23. Davey, R. T., Boenning, C. M., Herpin, B. R., Batts, D. H., Metcalf, J. A., Wathen, L., Cox, S. R., Polis, M. A., Kovacs, J. A., and Falloon, J. (1994) Use of recombinant soluble CD4 Pseudomonas exotoxin, a novel immunotoxin, for treatment of persons infected with human immunodeficiency virus. J. Infect. Dis. 170, 1180-1188.
24. Ramachandran, R. V., Katzenstein, D. A., Wood, R., Batts, D. H., and Merigan, T. C. (1994) Failure of short-term CD4-PE40 infusions to reduce virus load in human immunodeficiency virus-infected persons. J. Infect. Dis. 170, 1009-1013.
25. Pai, L. H., Bookman, M. A., Ozols, R. F., Young, R. C., Smith, J. W., II, Longo, D. L., Gould, B., Frankel, A., McClay, E. F., Howell, S., Reed, E., Willingham, M. C., FitzGerald, D. J., and Pastan, I. (1991) Clinical evaluation of intraperitoneal Pseudomonas exotoxin immunoconjugate OVB3-PE in patients with ovarian cancer. J. Clin. Oncol. 9, 2095-2103.
26. Y damage human endothelial cells in an antibody-specific mode: relevance to vascular leak syndrome. Clin. Cancer Res. 1, 1589-1594.
27. Chiron, M. F., Fryling, C. M., and FitzGerald, D. F. (1994) Cleavage of pseudomonas exotoxin and diphtheria toxin by a furin-like enzyme prepared from beef liver. J. Biol. Chem. 269, 18167-18176.
28. Batra, J. K., Jinno, Y., Chaudhary, V. K., Kondo, T., Willingham, M. C., FitzGerald, D. J., and Pastan, I. (1989) Antitumor activity in mice of an immunotoxin made with anti-transferrin receptor and a recombinant form of Pseudomonas exotoxin. Proc. Natl. Acad. Sci. U.S.A. 86, 8545-8549.
29. Chaudhary, V. K., Queen, C., Junghans, R. P., Waldmann, T. A., FitzGerald, D. J., and Pastan, I. (1989) A recombinant immunotoxin consisting of two antibody variable domains fused to Pseudomonas exotoxin. Nature 339, 394-397.
30. Brinkmann, U., Pai, L. H., FitzGerald, D. J., Willingham, M., and Pastan, I. (1991) B3(Fv)-PE38KDEL, a single-chain immunotoxin that causes complete regression of a human carcinoma in mice. Proc. Natl. Acad. Sci. U.S.A. 88, 8616-8620.